REPLIX 分数是由锐璞团队独创的一个衡量美股中小医药企业的框架。这个框架覆盖了评估中小药企的6个重要因素。这6个因素正好可以用REPLIX 6个字母来表达。REPLIX分数是锐璞投资流程的一个重要组成部分,可以优化选股过程,避开投资风险。
REPLIX 分数六大要素
Risk/Reward Ratio
(风险收益比例)
Events/Catalyst
(近期催化剂)
Product / Pipeline
(研发管线)
Long Term Financial Strength
(长期财务状况)
Institution Support / Insider Ownership
(知名机构以及管理层持股情况)
X - X factor
(市场热点)
股票 代码 |
公司 名称 |
Replix 分数 |
R - Risk/ Reward Ratio |
E - Events/ Catalyst |
P - Product/ Pipeline |
L - Long Term/ Financial Strength |
I - Inst. Support/ Insider Ownership |
X - X factor |
更新 时间 |
---|---|---|---|---|---|---|---|---|---|
KPTI | Karyopharm Therapeutics Inc | * | * | * | * | * | * | * | 2021-03-09 |
VTGN | Vistagen Therapeutics | * | * | * | * | * | * | * | 2021-03-09 |
RGNX | Regenxbio | * | * | * | * | * | * | * | 2021-03-09 |
MRSN | Mersana Therapeutics Inc | * | * | * | * | * | * | * | 2021-03-09 |
MGTX | MeiraGTx Holdings PLC | * | * | * | * | * | * | * | 2021-03-09 |
AKRO | Akero Therapeutics Inc | * | * | * | * | * | * | * | 2021-03-09 |
BCRX | BioCryst Pharmaceuticals, Inc. | * | * | * | * | * | * | * | 2021-03-08 |
ABEO | Abeona Therapeutics Inc | * | * | * | * | * | * | * | 2021-03-07 |
XAIR | Beyond Air Inc | * | * | * | * | * | * | * | 2021-03-07 |
MIST | Milestone Pharmaceuticals Inc | * | * | * | * | * | * | * | 2021-03-07 |